Download the App!

show episodes
 
Loading …
show series
 
On this episode, we are joined by P4 MUSC students Kaleigh Steelman and Emilie Parkman. We disucss the management and treatment options for atopic dermatitis. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We continue to partner with freeCE to provide listeners …
 
Jia Yin Townley, PharmD, BCPS, describes the pathophysiology of short bowel syndrome, identifies the medications used to manage short bowel syndrome and recognizes ways to optimize medication regimens for short bowel syndrome patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Sc…
 
On this episode, we discuss the various treatment options available for managing allergic rhinitis. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We continue to partner with freeCE to provide listeners with the opportunity to claim 1-hour of continuing educatio…
 
On this episode, we are joined by 4th year pharmacy students Olivia Schad and Austin Dew. We discuss a patient case involving asthma and substance use disorder. Thanks for listening! We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx …
 
Sydney E. Schultz, PharmD, @SydneyPharmD identifies presentation, prognostic factors and pathology associated with cancer of unknown primary, reviews historical treatment approaches, and discusses the role for use of molecular profiling to guide treatment. Twitter: @SydneyPharmD For more pharmacy content, follow Mayo Clinic Pharmacy Residency Progr…
 
On this episode, we are joined by Dr. Carly Floyd, PharmD, AAHIVP, CDCES, TTS, to discuss HIV pre-exposure prophylaxis (PrEP). Dr. Floyd is a clinical pharmacist and the PGY1 community pharmacy residency program director at Southwest CARE center. She is also the clinical director at the University of New Mexico AIDS Education & Training Center (UNM…
 
Joseph C. Osborne II, PharmD, @JOzempic describes the pharmacology of aducanumab, summarizes the clinical literature and approval process for aducanumab, and discusses stewardship considerations of aducanumab. Twitter: @JOzempic For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, …
 
On this episode, we discuss the opportunistic infections that affect patients with HIV and low CD4 counts. We review coccidioidomycosis, pneumocystis, histoplasmosis, toxoplasma, cryptococcal meningitis, and mycobacterium avium complex (MAC). Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listeni…
 
Megan L. Grochowski, PharmD, reviews the incidence of common Crotalidae snake envenomation in the United States, describes the progression of signs and symptoms associated with snakebites, explains the role, use, and administration of antivenom in snakebites, and reviews other interventional therapies utilized in the management and stabilization of…
 
On this episode, we are joined by Dr. Nina Lathia, BScPhm, RPh, MSc, PhD, to discuss the process of developing and managing a drug formulary. Dr. Lathia is a pharmacist and health economist in Toronto, Canada. She defines a drug formulary and explains some of the criteria used to establish a specific formulary. She also reviews some of the followin…
 
Patrick M. Wieruszewski, PharmD, BCCCP, describes the mechanisms of the renin-angiotensin system and its interplay in vasodilatory shock, reviews emerging data surrounding the use of angiotensin II in vasodilatory shock and identifies clinical shock scenarios where angiotensin II may be of most benefit. For more pharmacy content, follow Mayo Clinic…
 
On this episode, we review several drugs that have been approved by the FDA over the last year. The list of drugs that we review are below: Brexafemme (ibrexafungerp) Wegovy (semaglutide) Aducanumab (Aduhelm) Kerendia (finerenone) Zimhi (naloxone hydrochloride) Tyrvaya (varenicline) Nasal Spray PreHevbrio (hepatitis B vaccine (recombinant) Verquvo …
 
Mohammad B. Najib, Pharm.D., BCPS, describes the pathophysiology of Neuroleptic Malignant Syndrome (NMS), lists risk factors involved in the disease process, identifies the diagnostic criteria and an overview of the signs and symptoms, and examines management and treatment options. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Pr…
 
On this episode, we discuss dry eye disease (also known as keratoconjunctivitis sicca). We give some basic background information including pathophysiology and signs/symptoms. We then compare and contrast the various artificial tear products based on the information from "Artificial tears potpourri: a literature review" (PubMed ID below). We then d…
 
Rachel J. Johnson, Pharm.D., recalls common symptoms of Guillain-Barré Syndrome, describes the association between COVID-19 vaccines and Guillain-Barré Syndrome, and identifies appropriate treatment for a patient with Guillain-Barré Syndrome. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garret…
 
On this episode, we review the treatment of dermatophyte (tinea) infections. Hey guys, we’re happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast! We continue to partner with freeCE to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. …
 
Aeryana N. Beaudrie-Nunn, Pharm.D. (@ABeaudrieRx), identifies the rationale for immunodulatory therapy in COVID-19, explores clinical trial data regarding the use of Baricitinib in hospitalized patients with COVID-19, and defines the patient context where Baricitinib use is most appropriate. For more pharmacy content, follow Mayo Clinic Pharmacy Re…
 
Andrew J. Jatis, Pharm.D. (@jatis_rx), recognizes the clinical heterogeneity of cardiogenic shock and its impact on clinical outcomes, describes current literature assessing vasopressors and inotropes in the management of cardiogenic shock, and determines an optimal pharmacologic regimen for the treatment of cardiogenic shock given individual patie…
 
Jennifer M. Nelson, Pharm.D., outlines Center for Disease Control and Prevention (CDC) guidelines for initial care of refugee populations, recognizes unique disease states, genetics, and cultural considerations for the Afghan refugee population, and identifies treatment for unique disease states in the Afghan refugee population. For more pharmacy c…
 
On this episode, we review the management of Crohn's Disease. We go over the newest guidelines and some of the supporting clinical data. We end by discussing the U.S. Preventive Services Task Force's colorectal cancer screening recommendations. Once again, we’re excited to announce that our listeners can claim ACPE-accredited continuing education f…
 
Robert J. Schroeder, Pharm.D., explains the pharmacological principles of sacubitril/valsartan, recognizes the evidence favoring sacubitril/valsartan in heart failure and describes how to initiate sacubitril/valsartan. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., …
 
On this episode, we review the data for tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes a new medication that is being investigated. We discuss the unique mechanism of action and summarize the data from the SURPASS st…
 
Katelyn (Kate) R. Neverman, Pharm.D., identifies three continuous glucose monitors (CGMs) approved by the FDA, describes the difference between glucose management indicator (GMI) and hemoglobin A1c and discusses how to interpret glycemic data using an Ambulatory Glycemic Profile (AGP) report. For more pharmacy content, follow Mayo Clinic Pharmacy R…
 
On this episode, we review medication regimens for special patient populations. We start with a quick overview of CYP450 drug-drug interactions. We then discuss safety conerns when starting medications in a patient that is pregnant, is at an increase risk for a bleed, renal impairment, and hepatic impairment. Once again, we’re excited to announce t…
 
Divya A. Khandekar, Pharm.D., M.S., compares and contrasts the etiologies of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), discusses primary literature examining current treatment options for HFpEF and identifies the role of SGLT2 inhibitors in the treatment of HFpEF. For more pharm…
 
On this episode, we discuss some of the basics of treating a patient with hepatitis C. We list the labs that should be drawn prior to starting treatment as well as non-invasive ways of assessing fibrosis/cirrhosis. We also review some information about the pangenotypic medications, Epclusa and Mavyret. Click the following link to see the upcoming e…
 
Kyle A. Hess, Pharm.D., recognizes the clinical presentation of beta-lactam induced neurotoxicity, identifies risk factors associated with developing beta-lactam induced neurotoxicity and describes the relationship between drug levels of beta-lactams and development of neurotoxicity. For more pharmacy content, follow Mayo Clinic Pharmacy Residency …
 
On this episode, we are joined by Dr. Amelia Furbish, PharmD (PhD candidate) and P4 USC College of Pharmacy student, Jordan Staires, to discuss various classes of psychoactive research pharmaceuticals. We review benzodiazepines, cathinones, tryptamines, phenethylamines, Kratom, benzedrex, phenibut, and more. While many medications in these classes …
 
Nikitha Yagnala, Pharm.D., defines iatrogenic withdrawal syndrome in critically ill patients, identifies risk factors for iatrogenic withdrawal syndrome and reviews the current evidence for management of iatrogenic withdrawal syndrome. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Sc…
 
Jo Ann Leal, Pharm.D., describes the epidemiology of stress ulcers and stress ulcer prophylaxis in select critically ill patients, evaluates the literature that examines the incidence of gastrointestinal bleeding in patients receiving corticosteroids and the outcomes of stress ulcer prophylaxis in patients on dual antiplatelet therapy and analyzes …
 
On this episode, Cole and I are joined by Trevor Walker, PharmD Candidate 2022. We begin by comparing and contrasting the original SSRIs as well as new agents like vortioxetine and vilazodone. We then review some serotonin (5-HT) receptors and how their activity (or inhibition) determine and mitigate outcomes and adverse effects. We close by review…
 
Kaylee A. Clark, Pharm.D., reviews the types of hypersensitivity reactions, discusses the pathophysiology and common features of different hypersensitivity reactions to chemotherapeutic agents and describes appropriate prevention and management strategies for hypersensitivity reactions. For more pharmacy content, follow Mayo Clinic Pharmacy Residen…
 
Loading …

Quick Reference Guide

Copyright 2022 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login